Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Diabetes Complications. 2017 Sep 19;32(2):157–163. doi: 10.1016/j.jdiacomp.2017.09.009

Table 1.

Baseline characteristics of study participants according to prior hypoglycemic events

Severe Hypoglycemia P value
NO YES
N (%) 1,498,416 (99.3) 10,864 (0.7)
Age (year-old) 54.9 ± 10.9 61.3 ± 9.6 <0.001
Age (≥55 year-old) (%) 775,460 (51.8) 8,213 (75.6) <0.001
Sex (male)(%) 957,587 (63.9) 5,600 (51.6) <0.001
Height (cm) 162.9 ± 9.0 159.6 ± 9.1 <0.001
Weight (kg) 66.5 ± 11.2 61.5 ± 10.9 <0.001
BMI (kg/m2) 25.0 ± 3.3 24.1 ± 3.5 <0.001
BMI (≥ 25 kg/m2) (%) 719,520 (48.0) 4,171 (38.4) <0.001
Systolic blood pressure (mmHg) 130.7 ± 17.0 130.7 ± 17.9 0.9919
Diastolic blood pressure (mmHg) 80.5 ± 10.8 78.8 ± 10.7 <0.001
Current smoking (%) 412,025 (27.5) 2,051 (18.9) <0.001
Drinker (heavy) (%) 74,598 (5.0) 486 (4.47) 0.0159
Exercise (yes) (%) 759,217 (50.7) 4,802 (44.2) <0.001
Hypertension (yes) (%) 798,214 (53.3) 7,251 (66.7) <0.001
Low economic status (%) 397,663 (26.5) 2,838 (26.1) 0.328
Rural area (%) 872,444 (55.6) 6,716 (62.5) <0.001
Hyperlipidemia (%) 471,195 (31.5) 3,853 (35.5) <0.001
Heart failure (%) 33,280 (2.2) 769 (7.1) <0.001
Myocardial infarction (%) 23,035 (1.5) 706 (6.5) <0.001
Ischemic stroke (%) 83,825 (5.6) 1,971 (18.1) <0.001
End stage renal disease (%) 1,746 (0.1) 250 (2.3) <0.001
Hyperthyroidism (%) 54,969 (3.7) 805 (7.4) <0.001
Total cholesterol (mg/dL) 201.4 ± 43.0 191.2 ± 45.6 <0.001
Fasting glucose (mg/dL) 149.6 ± 51.6 145.4 ± 67.7 <0.001
Antidiabetic therapy
  Insulin (%) 94,582 (6.3) 3,224 (29.7) <0.001
  Sulfonylurea (%) 661,037 (44.1) 7,037 (64.8) <0.001
  Metformin (%) 504,599 (33.7) 5,785 (53.3) <0.001

Data are mean ± SD or number (%). BMI, body mass index